Zomedica Completes Verification of Three More Assays for its TRUFORMA™ Point-of-Care Diagnostic Platform
20 mai 2020 16h05 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 20, 2020 (GLOBE NEWSWIRE) -- Zomedica (NYSE American: ZOM), a veterinary diagnostic company, announced today that it has completed the final verification of three additional...
Zomedica Announces First Quarter 2020 Financial Results
11 mai 2020 16h20 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 11, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, today reported consolidated...
Zomedica Completes Verification of its TRUFORMA™ Point-of-Care Diagnostic Platform and the First Assay, Canine total T4
21 avr. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., April 21, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, announced today that it has...
Zomedica Provides Corporate Update
13 avr. 2020 19h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., April 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced that, on...
Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public Offering
07 avr. 2020 23h32 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., April 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing...
Zomedica Pharmaceuticals Corp. Announces Public Offering
07 avr. 2020 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., April 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced that it has...
Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results
26 févr. 2020 17h24 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, announced consolidated financial...
Zomedica Announces Completion of $2.5 Million Registered Direct Offering
14 févr. 2020 16h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM)(“Zomedica” or “Company”), a veterinary diagnostic company, announced today the completion of...
Zomedica Announces $2.5 Million Registered Direct Offering
12 févr. 2020 08h43 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, announced today that it has...
Zomedica Files U.S. Patent Application for Fecal Parasite Detection
11 févr. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM)(“Zomedica” or “Company”), a veterinary diagnostic company, announced today that the Company...